Zelira Therapeutics Ltd News

Zelira Therapeutics Ltd: Proposed issue of securities - ZLD

Nov 14 14:34

Zelira Therapeutics Ltd: Results of Meeting

Nov 14 09:47

Zelira Therapeutics Ltd: 2024 Annual General Meeting Presentation

Nov 14 08:02

Zelira Therapeutics Ltd: Appendix 4C Cash Flow Report

Oct 29 09:39

Zelira Therapeutics Ltd: September 2024 Quarterly Activities Report

Oct 29 09:39

Zelira Therapeutics Ltd: Letter to Shareholders

Oct 11 12:52

Zelira Therapeutics Ltd: Notice of Annual General Meeting/Proxy Form

Oct 11 12:51

Zelira Therapeutics Ltd: Investor Webinar - HOPE FDA Program Update

Sep 20 08:42

Zelira Therapeutics Ltd: Notice of Investor Webinar - HOPE FDA Program Update

Sep 18 06:18

Zelira Therapeutics Ltd: AGM Date and Closing Date for Director Nominations

Sep 12 14:54

Zelira Therapeutics Ltd: Appendix 4G

Aug 28 11:35

Zelira Therapeutics Ltd: Appendix 4E and Financial Report to Shareholders

Aug 28 11:35

Zelira Therapeutics Ltd: Zelira Receives Positive FDA Minutes from Pre-IND Meeting

Aug 22 07:47

Zelira Therapeutics Ltd: Appendix 4C Cash Flow Report

Jul 30 07:05

Zelira Therapeutics Ltd: June 2024 Quarterly Activities Report

Jul 30 07:04

Zelira Therapeutics Ltd: Zelira secures leading patents for HOPE 1 and HOPE 2

Jul 16 06:25

Zelira Therapeutics Ltd: ZLD Advances HOPE Autism Drug Program with U.S FDA Meeting

Jul 11 07:58

Zelira Therapeutics Ltd: Zelira Receives USD$1.4Million Unsecured Loan from Chairman

Jul 4 06:26

Zelira Therapeutics Ltd: ZLD secures US$1.4M unsecured Chairman loan facility

Jul 1 07:30

Zelira Therapeutics Ltd: HOPE SPV receives US$681,000 third tranche of funding

May 23 06:50